N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
about
GABA and Glutamate Transporters in BrainRecent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's DiseaseThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingThe novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapyn-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's diseaseGlutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1)The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNSAntioxidant Therapies for Ulcerative Dermatitis: A Potential Model for Skin Picking DisorderEffects of isoflurane on learning and memory functions of wild-type and glutamate transporter type 3 knockout mice.Genetic deletion of the neuronal glutamate transporter, EAAC1, results in decreased neuronal death after pilocarpine-induced status epilepticus.Glutamate as a neurotransmitter in the healthy brainCysteine transport through excitatory amino acid transporter 3 (EAAT3).Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats.The importance of the excitatory amino acid transporter 3 (EAAT3)Group I mGluR-regulated translation of the neuronal glutamate transporter, excitatory amino acid carrier 1.Augmented cystine-glutamate exchange by pituitary adenylate cyclase-activating polypeptide signaling via the VPAC1 receptor.Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated NeurodegenerationFinding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse geneticsCharacterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatmentComprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.The Ca2+/Mn2+ ion-pump PMR1 links elevation of cytosolic Ca(2+) levels to α-synuclein toxicity in Parkinson's disease models.Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging RatsAn increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderlyImpaired glutathione synthesis in neurodegeneration.N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1).Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease.The ongoing pursuit of neuroprotective therapies in Parkinson disease.Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons.Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.EAAT and Xc⁻ Exchanger Inhibition Depletes Glutathione in the Transformed Human Lens Epithelial Cell Line SRA 01/04.An FITC-BODIPY FRET couple: application to selective, ratiometric detection and bioimaging of cysteine.Rhythmic oscillations of the microRNA miR-96-5p play a neuroprotective role by indirectly regulating glutathione levels.Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.1,2,3,4,6-penta-O-galloyl-β-D-glucose protects PC12 Cells from MPP(+)-mediated cell death by inducing heme oxygenase-1 in an ERK- and Akt-dependent manner.
P2860
Q21090476-43A456D1-97B2-448D-BD34-9D90DE0D1590Q26765084-845F11B1-93EE-4DDD-918A-074C41EFA426Q26864995-C7E4E8F8-1451-4560-BB17-FDA279726E78Q27301297-54BC6A59-3E28-4BFA-A72C-412FBFFED58BQ27334018-4800FC73-C578-4F10-8402-390AF94DB636Q28085756-EBBAAD95-ABD8-4230-ACA6-3819DFA08DF5Q28265451-745B91BB-C3C3-4D47-9EFF-616149EB4C9BQ28546450-289FA239-9F42-4051-AD30-57EB1BAC0B34Q30454874-474B9478-BB2F-47DF-9A08-CB5CAA047B85Q33748210-4750775C-5BA0-4603-9379-706EF1BA0387Q34048502-F187E19F-8EE2-4CDD-847F-7992EC04E596Q34282413-44F7E3A6-D83E-4D90-AFC4-0CFBE2E9033BQ34345646-1F41DF35-FBD7-42A6-BF2F-785414CA8432Q34528594-7F7E2338-E1B8-4F75-8684-BDCEF81CA687Q34939766-27CA08B5-90E7-4843-82BE-A1575419368CQ35024151-F24EF1A5-74EF-45CB-8C58-AD6CE135DD33Q35101698-88A5C8B1-52FF-414D-B75F-F694574861E3Q35237718-1F5BCD83-36C1-4A55-A6B5-62CE3F4BC4C3Q35341623-F0B99161-45D6-4D4E-9A35-F186E00DA286Q35928836-64E6DDF9-2EF9-4525-9DFE-CFCCACE7613DQ36056224-98700A07-CD8E-4111-AF2A-3F1C9B3F6C0DQ36603128-782AA66F-212B-4A5B-9922-95ACB3229E32Q36968109-B0D14B52-E2DD-46F9-8C12-9C9D9817D835Q37051146-271A5D65-57D0-45CF-B1A2-039099D56097Q37219282-B36A2F0D-0CCB-46B5-B406-A3270688BFB3Q37291406-70109AEC-265B-479D-BCD6-72732D50CA40Q37603362-66B00C70-79DB-4E33-806E-950DC06C3AD7Q37619972-ACACF6C5-4550-4EC3-814A-FB76D35383EFQ38086728-1EFD2D9F-FB8B-45DD-89ED-F3330B96E431Q38155806-BBE5C714-62D3-45E8-B88F-1D26505E4E4DQ38275171-70C4D296-C755-4A12-BA35-1D6A6866A1D8Q38618048-062F4741-EE4B-4431-AA24-70827A94EDAFQ38630519-068BB02B-3B85-444B-BE0C-BCE0FD23B4BEQ38842550-941D9BBB-D4BE-4E77-A6CA-34FCA182FE4DQ38861849-745D025A-9F5C-4496-9F8D-DB3E38D97D17Q38884002-5506EBF9-FE80-4E45-AD0B-FF608D4A648DQ38945017-9F690455-47A9-4528-A677-2B6B96A67B23Q38997504-54C62B5F-276D-4840-A04A-0B4C0EA0C17CQ39018853-9D6F3984-874E-4FB7-A11E-EA87F616638DQ39257847-9F3F6742-7657-4588-8C82-2926515EEFD6
P2860
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
@en
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
@nl
type
label
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
@en
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
@nl
prefLabel
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
@en
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
@nl
P2093
P2860
P50
P356
P1433
P1476
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse
@en
P2093
Angela M Brennan
Ari E Berman
Reno C Reyes
Sang Won Suh
Wai Yee Chan
Ylva Edling
P2860
P304
P356
10.1002/ANA.22162
P577
2010-11-23T00:00:00Z